The ASSURE Study: HIV-1 Suppression Is Maintained with Bone and Renal Biomarker Improvement 48 Weeks after Ritonavir Discontinuation and Randomized Switch to Abacavir/Lamivudine + Atazanavir. HIV Medicine, 17(2): 106-117.

In by AHF

Supranormal Thymic Output up to 2 Decades after HIV-1 Infection. AIDS, 30: 701-711.
Gender and HIV Testing Service Uptake: Trend in Northern Nigeria. Journal of AIDS & Clinical Research, 7(12): 1-4.
Download
File Type: pdf
Categories: 2016
Tags: 2015-2019
Author: Bhatti L, DeJesus E, Edelstein H, Margolis DA, Ross LL, Shaefer MS, Small CB, Weinberg WG, Wohl DA, Zhao HH